Tag: PET/CT
-
Unusual PET-CT Scan Patterns Linked to GLP-1 Weight-Loss Drugs
Overview: A new imaging wrinkle around popular GLP-1 medications GLP-1 receptor agonists, a class of drugs that has surged in popularity for weight loss and type 2 diabetes management, are facing fresh scrutiny. While these medications—sold under names like Ozempic, Wegovy, and Mounjaro—continue to help many shed pounds, doctors are now noting unfamiliar patterns on…
-
Unusual GLP-1 Drug Side Effect Could Skew PET-CT Scans, Study Warns
GLP-1 drugs are reshaping weight loss—and now imaging, too GLP-1 receptor agonists, best known by brand names like Ozempic, Wegovy, and Mounjaro, have surged in popularity for their powerful weight‑loss effects. But as their use has exploded—driven by a 700% rise in the United States from 2019 to 2023—so too have reports of unusual side…
-
GLP-1 Drugs May Skew PET-CT Scans: A Hidden Risk for Cancer Detection
Understanding the emerging imaging challenge with GLP-1 medications GLP-1 receptor agonists, including popular drugs like Ozempic, Wegovy, and Mounjaro, have transformed weight loss and diabetes management. Yet as usage surged—reported to have risen about 700% in the United States from 2019 to 2023—so have reports of unusual side effects. A less obvious consequence is their…
-
Ga-68 DOTANOC PET/CT in Cardiac Sarcoidosis: A New Tool for Assessing Therapy Response
Overview: Ga-68 DOTANOC as an inflammation tracer in cardiac sarcoidosis Cardiac sarcoidosis (CS) is a granulomatous inflammatory disease affecting the heart, often with serious outcomes if not treated appropriately. Immunosuppressive therapy, typically steroids with possible addition of other agents, remains the mainstay of management. Traditional imaging has focused on identifying disease activity and guiding therapy.…
-
Ga-68 DOTANOC PET/CT: A New Lens for Assessing Therapy Response in Cardiac Sarcoidosis
Introduction Cardiac sarcoidosis is an inflammatory granulomatous disease of the heart that carries substantial morbidity and mortality if not properly managed. Immunosuppressive therapy, often steroids, remains the cornerstone of treatment. While traditional imaging modalities help diagnose cardiac involvement, tracking the response to therapy requires reliable, repeatable biomarkers of inflammation. Recent prospective data from a study…
-
Ga-68 DOTANOC PET/CT for Response Assessment in Cardiac Sarcoidosis: A Prospective Study
Introduction Cardiac sarcoidosis is an inflammatory granulomatous disease of the heart that carries significant morbidity and mortality. Immunosuppressive therapy is the cornerstone of treatment, aiming to reduce myocardial inflammation and preserve cardiac function. This prospective observational study evaluates the usefulness of Ga-68 DOTANOC PET/CT, a somatostatin receptor imaging modality, for assessing treatment response in cardiac…